Tango Therapeutics, Inc. (TNGX) stock
TNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/30128% above fair value
$21.89−0.22 (-1.00%)
Close on Nov 18, 2026Market cap $3.69BP/E –Yield –
Tango Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Tango Therapeutics's market cap was $4.33B on Nov 11, 2026, against $1.22B a year earlier. Over the last 5 years it ranged from $147.59M to $4.51B, with a median of $743.95M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $4.33B | +338.3% |
| 2025 | Dec 31, 2025 | $988.48M | +197.8% |
| 2024 | Dec 31, 2024 | $331.91M | -67.1% |
| 2023 | Dec 29, 2023 | $1.01B | +57.9% |
| 2022 | Dec 30, 2022 | $638.49M | -33.3% |
| 2021 | Dec 31, 2021 | $957.73M | +494.4% |
| 2020 | Dec 31, 2020 | $161.13M | – |
See a number that looks wrong?